• SENSEX 76,318.78
    -625.50 (--0.81%)
  • BANKNIFTY 57,409.60
    -615.35 (--1.06%)
  • Infosys
    1,118.55 984.00(%)
  • Interglobe Aviat
    4,900.30 3,894.80(%)
  • IFCI
    96.67 95.75(%)
  • Coal India
    422.35 490.90(%)
  • Hero Motocorp
    5,196.35 4,671.55(%)
  • Bharat Forge
    2,011.80 1,105.45(%)
  • Havells India
    1,197.00 1,123.85(%)
  • Shreeji Ship. Gl
    649.00 704.90(%)
  • Milky Mist Dairy
    255.10 233.95(%)
  • HDFC Bank
    700.15 698.50(%)
  • Dhoot Transmission
    1,593.30 1,673.50(%)
  • TVS Motor Co.
    4,091.75 3,228.00(%)
  • Tempsens Instruments
    588.70 635.00(%)
  • T B Z
    430.40 366.50(%)
  • Cupid
    282.00 298.95(%)
  • Symbiotec Pharma
    1,152.80 1,173.80(%)
  • Sansera Enginee.
    3,786.00 1,245.30(%)
  • Netweb Technol.
    5,082.70 2,200.30(%)
  • Axis Bank
    1,249.80 1,041.30(%)
  • Ather Energy
    1,707.45 445.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syncom Formulations (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3544.0
  • ISIN : INE312C01025
20.07 1 (2.98%)
  • As on 02 Sep 2026 (EOD)

  • Today’s Low

    18.76

  • Today’s High

    20.20

  • Open

    19.50

  • Perv Close

    19.49

  • 52W Low

    10.21

  • 52W High

    20.38

Key Indicators

  • P/E(TTM)

    22.30

  • Mar.Cap (₹Cr.)

    1,886.58

  • Div & Yield %

    0.00

  • Book Value(₹)

    4.39

  • Debt-Equity Ratio

    2.98

  • AGM Date

    01-Sep-2026

  • EPS

    0.90

  • P/E Ratio

    22.30

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    1,886.58

  • RONW (%)

    9.30

  • ROCE (%)

    10.91

Score Board

  • Equity (₹ in Cr.)

    94.00

  • BV (₹)

    4.40

  • Sales( ₹ in Cr.)

    486.57

  • NP (in Cr.)

    75.98

  • NP Var(%)

    56.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    1,886.58

  • 52 Week High

    20.38

  • 52 Week Low

    10.21

  • Price BSE

    20.0

  • Price NSE

    20.00

  • Market Capital( in Cr.)

    1,886.58

  • P/C Ratio

    22.80

  • P/E Ratio

    24.70

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 462.85 258.36 224.64 219.66 244.81 205.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 462.85 258.36 224.64 219.66 244.81 205.51
Other Income 17.20 13.10 14.62 12.02 7.17 5.22
Stock Adjustments 10.62 2.18 -0.05 -3.32 4.05 3.70
Total Income 490.67 273.64 239.21 228.36 256.03 214.43
EXPENDITURE :            
Raw Materials 317.51 157.74 142.07 137.23 165.51 155.32
Power and Fuel Cost 5.62 6.13 5.31 4.38 3.84 3.93
Employee Cost 50.56 33.57 24.44 20.73 18.24 15.80
Other Manufacturing Expenses 2.88 2.39 3.19 2.26 2.09 2.02
Selling and Administration Expenses 39.22 29.62 27.29 29.71 19.79 13.76
Miscellaneous Expenses 4.00 3.03 2.41 2.00 1.34 1.65
Employee Benefit Expenses 50.56 33.57 24.44 20.73 18.24 15.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 419.79 232.47 204.71 196.32 210.81 192.47
Operating Profit 70.88 41.18 34.51 32.05 45.22 21.96
Interest 1.03 4.70 3.40 1.93 0.48 0.61
Gross Profit 69.85 36.48 31.11 30.12 44.74 21.35
Depreciation 5.19 4.72 4.54 3.95 4.03 4.06
Profit Before Tax 64.66 31.76 26.57 26.17 40.71 17.29
Current Tax 14.45 7.58 6.65 6.25 11.30 4.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.33 0.55 -0.15 0.14 0.23 -1.40
Reported Net Profit 48.87 23.62 20.07 19.79 29.17 14.25
Extraordinary Items 0.32 0.55 0.14 0.03 0.10 -0.04
Adjusted Net Profit 48.55 23.07 19.93 19.76 29.07 14.29
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 102.99 79.36 62.11 42.32 13.15 11.40
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 2.82 0.00 0.00 12.50
P & L Balance carried down 151.86 102.99 79.36 62.11 42.32 13.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 3.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.03 0.00 0.00
Earnings Per Share-Unit Curr 0.52 0.25 0.21 0.23 0.37 0.18
Earnings Per Share(Adj)-Unit Curr 0.52 0.25 0.21 0.23 0.37 0.18
Book Value 3.62 3.05 2.72 2.52 2.25 1.87
Book Value(Adj)-Unit Curr 3.62 3.05 2.72 2.52 2.25 1.87

Shareholding Pattern

  • Promoter Group

    50.57%

  • Public Share Holding

    49.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 83,061,125 8.84 83,061,125 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 392,286,474 41.73 392,286,474 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 475,347,599 50.57 475,347,599 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.00 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 4,500 0.00 4,500 1
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,280,678 0.35 3,280,678 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 18,925 0.00 18,925 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,311,103 0.35 3,311,103 19
2] Non Institution
Bodies Corporate 9,486,453 1.01 9,483,953 199
Clearing Members 317,562 0.03 317,562 22
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 17,047,220 1.81 16,944,720 2,035
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 9,959,452 1.06 9,959,452 1,744
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 61,145,776 6.50 61,145,776 141
Individuals holding nominal share capital up to Rs. 1 lakh 360,906,020 38.39 358,589,340 417,919
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,320,331 0.25 2,320,331 1
Sub Total 461,341,298 49.08 458,919,618 422,082
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 940,000,000 100.00 937,578,320 422,114

Company Background

Syncom Formulations (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syncom Formulations (India) Ltd
  • BSE Code : 3544.0
  • ISIN : INE312C01025

  • Incorporation Year

    1988

  • Registered Office

    7 Niraj Indl Estate Andheri(E)
    Off Mahakali Caves Rd, Mumbai,
    Maharashtra-400093

  • Telephone

    91-22-30887744

  • FAX

    91-22-30887755

  • Chairman

    ANKIT KEDARMAL BANKDA

  • Managing Director

    Rahul Vijay Bankda

  • Company Secretary

    Vaishali Agrawal

  • Auditor

    Sanjay Mehta & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Syncom Formulations (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syncom Formul. 20.07 480.04 462.85 22.30 18.44
Abbott India 26,135.85 7,217.19 6,929.05 34.40 43.78
Astrazeneca Phar 6,927.10 2,304.07 2,275.58 102.09 27.86
Glaxosmi. Pharma 2,994.70 3,932.76 3,790.20 47.84 58.17
Novartis India 1,584.60 398.23 356.27 40.02 16.64
Cipla 1,418.00 20,102.60 18,979.95 37.27 13.88
Bliss GVS Pharma 629.65 773.53 729.81 58.46 12.51
Amrutanjan Healt 499.10 520.13 502.55 26.73 24.16
Fermenta Biotec. 486.55 474.15 450.25 22.71 18.77
Guj. Themis Bio. 419.45 152.47 150.80 93.84 27.21
Ambalal Sarabhai 44.29 19.52 3.94 82.02 6.77